(CT ± SD) for the MCP-1 gene in the drug-naive group (controls) was (29.81 ± 0.73) and in post-OCP treated PCOS group (cases) was (29.01 ± 0.61) (p = 0.0001). The gene discussed is CCL2; the disease is polycystic ovary syndrome.